Cancer, Ovarian Completed Phase 1 Trials for DB00099 (Filgrastim)

Also known as: Cancer of the Ovary / Ovarian Cancer / Ovary Cancer / Cancer of Ovary / Ca ovary / Malignant tumor of ovary / Malignant neoplasm of ovary / Ovarian cancer NOS

IndicationStatusPhase
DBCOND0063542 (Cancer, Ovarian)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00002977Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete RemissionTreatment
NCT00002600Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial CancerTreatment
NCT00014456Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid TumorsTreatment
NCT00550784Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerTreatment